BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9195985)

  • 1. A CACCC box-like cis-regulatory element of the Epstein-Barr virus ED-L2 promoter interacts with a novel transcriptional factor in tissue-specific squamous epithelia.
    Nakagawa H; Inomoto T; Rustgi AK
    J Biol Chem; 1997 Jun; 272(26):16688-99. PubMed ID: 9195985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The keratinocyte-specific Epstein-Barr virus ED-L2 promoter is regulated by phorbol 12-myristate 13-acetate through two cis-regulatory elements containing E-box and Krüppel-like factor motifs.
    Jenkins TD; Nakagawa H; Rustgi AK
    J Biol Chem; 1997 Sep; 272(39):24433-42. PubMed ID: 9305903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
    Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
    DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.
    Chavrier P; Gruffat H; Chevallier-Greco A; Buisson M; Sergeant A
    J Virol; 1989 Feb; 63(2):607-14. PubMed ID: 2536096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
    J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transactivation of the human keratin 4 and Epstein-Barr virus ED-L2 promoters by gut-enriched Krüppel-like factor.
    Jenkins TD; Opitz OG; Okano J; Rustgi AK
    J Biol Chem; 1998 Apr; 273(17):10747-54. PubMed ID: 9553140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
    Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
    J Virol; 2017 May; 91(9):. PubMed ID: 28228591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R.
    Chevallier-Greco A; Gruffat H; Manet E; Calender A; Sergeant A
    J Virol; 1989 Feb; 63(2):615-23. PubMed ID: 2536097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp3 Transcription Factor Cooperates with the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein To Synergistically Activate Specific Viral and Cellular Gene Promoters.
    Chen LY; Chen LW; Peng KT; Hung CH; Chang PJ; Wang SS
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effect of Sp1 and Sp3 in regulation of the ED-L1E promoter of the EBV LMP 1 gene in human epithelial cells.
    Tsai CN; Lee CM; Chien CK; Kuo SC; Chang YS
    Virology; 1999 Sep; 261(2):288-94. PubMed ID: 10497114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the human reduced folate carrier promoter C: synergistic transactivation by Sp1 and C/EBP beta and identification of a downstream repressor.
    Payton SG; Whetstine JR; Ge Y; Matherly LH
    Biochim Biophys Acta; 2005 Jan; 1727(1):45-57. PubMed ID: 15652157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Perrigoue JG; Mertz JE
    J Virol; 2003 Jan; 77(1):199-207. PubMed ID: 12477825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A minimal murine Msx-1 gene promoter. Organization of its cis-regulatory motifs and their role in transcriptional activation in cells in culture and in transgenic mice.
    Takahashi T; Guron C; Shetty S; Matsui H; Raghow R
    J Biol Chem; 1997 Sep; 272(36):22667-78. PubMed ID: 9278425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.
    Ragoczy T; Miller G
    J Virol; 2001 Jun; 75(11):5240-51. PubMed ID: 11333906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
    Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
    J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus.
    Bulfone-Paus S; Dempsey LA; Maizels N
    Proc Natl Acad Sci U S A; 1995 Aug; 92(18):8293-7. PubMed ID: 7667284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the delta-globin gene by the beta-globin gene CACCC motif.
    Ristaldi MS; Casula S; Porcu S; Marongiu MF; Pirastu M; Cao A
    Blood Cells Mol Dis; 1999; 25(3-4):193-209. PubMed ID: 10575545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter-proximal regulatory elements involved in oriP-EBNA1-independent and -dependent activation of the Epstein-Barr virus C promoter in B-lymphoid cell lines.
    Nilsson T; Zetterberg H; Wang YC; Rymo L
    J Virol; 2001 Jul; 75(13):5796-811. PubMed ID: 11390581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.